Fall-out between Reckitt Benckiser and Futura over CSD 500

The British firm that says it has created an erection sustaining condom has fallen out with its marketing partner, Reckitt Benckiser, forcing it to go ahead with production on its own.

Futura Medical says it was unable to find: "common ground acceptable to both parties in respect of their continued development and commercialisation of the CSD500 condom."

MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

The group's Chief Executive, James Barder, said: "Futura has received considerable interest in CSD500 from potential marketing partners. We are therefore confident of relicensing the product on attractive commercial terms and of creating significant value for shareholders."

The market was less than happy with the news. Futura's stock is down 19% at 11:31.

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.